This trial compares PET-CT imaging using [18F]-FDG to RefleXion Medical Radiotherapy System (RMRS) imaging to potentially improve radiation therapy targeting of cancer cells.
- Blood Cancer
1 Primary · 1 Secondary · Reporting Duration: Up to 72 hours
Awards & Highlights
1 Treatment Group
Device ([18F]-FDG PET-CT, X1 RMRS PET-CT)
1 of 1
20 Total Participants · 1 Treatment Group
Primary Treatment: Device ([18F]-FDG PET-CT, X1 RMRS PET-CT) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there currently an opportunity to join this experiment?
"The latest update on clinicaltrials.gov implies that this medical research is now welcoming applicants. This was first advertised on March 15th, 2023 and the most recent changes were made to the listing in May 3rd of the same year." - Anonymous Online Contributor
How many participants are participating in this scientific experiment?
"Affirmative. According to the information on clinicaltrials.gov, this research project is actively enrolling participants at 1 location and a total of 20 individuals are required for completion. The trial was initially published on March 15th 2023 with its last update occurring on May 3rd2023." - Anonymous Online Contributor